⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Accriva Diagnostics, Inc.: directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2

Medical DevicesSource: FDA (device) · Date: 2026-06-24

Read the official notice at FDA (device) →

Share on XFacebookRedditEmail

Get alerts for Accriva Diagnostics

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (device) record. If anything differs, the official notice is correct.

Company / brand
Accriva Diagnostics, Inc.
Product
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
Reason / hazard
Assayed Whole blood control contains labeling with incorrect performance range.
Classification
Class II
Status
Ongoing
Distribution / sold at
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MT, NC, NJ, NM, NY, OH, OK, PA, SC, TN, TX, VA, VT, WA, WI, WV and the countries of Canada, Hong Kong, Spain.
Recall initiated
2026-04-30
Code info
Lot #: A6DLA001 Unique Device Identifier: 10711234170373
Product quantity
6060
Voluntary mandated
Voluntary: Firm initiated
City
San Diego
State
CA
Country
United States
Event id
98979
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.